D-685
D-685, a prodrug of D-520, exhibits higher in vivo anti-Parkinsonian efficacy in a reserpinized Parkinson's disease (PD) animal model than the parent D-520. D-685 reduces accumulation of human α-synuclein (α-syn) protein. D-685 exhibits facile brain penetration.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2893801-00-6
- 分子式: C32H39N3O3
- 分子量:513.67
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
α-synuclein アイソフォーム固有の製品をすべて表示
More
生物活性
|
α-synuclein Aggregation |
D-685 (10 μmol/kg; ip) is not only highly efficacious in reversing akinesia in male and female Sprague-Dawley rats weighing 220-225 g, compared to Reserpine (HY-N0480; 5.0 mg/kg; SC) alone, but also demonstrates significant enhancement of locomotion for the entire duration of the 6 h study[1].
D-685 exhibits facile penetration into the brain under ip administration with a high brain-to-plasma ratio (B/P: 4)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Five-month-old D-Line α-syn tg Balb/c female mice 20-22 g[1]
-
Dosage:12 mg/kg
-
Administration:Intraperitoneally daily for 1 month
-
Result:Caused a significant reduction in α-syn accumulation in the neocortex and the striatum and a trend toward a reduction in the CA3 region of the hippocampus.
There was a significant reduction in phospho-α-syn accumulation in all regions examined.
化学情報
-
CAS 番号 2893801-00-6
-
分子量 513.67
-
分子式 C32H39N3O3
-
SMILES
OC1=C2CC[C@H](N(CCN3CCN(C4=CC=C(C5=CC=C(OCO6)C6=C5)C=C4)CC3)CCC)CC2=CC=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)